Related Experiment Video
Updated: Jun 17, 2026

11:35
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Psychometrics and normative data for the Multiple Sclerosis Functional Composite: replacing the PASAT with the Symbol
A S Drake1, B Weinstock-Guttman, S A Morrow
1Department of Neurology, State University of New York (SUNY) at Buffalo School of Medicine, Buffalo, NY, USA.
Summary
The Symbol Digit Modalities Test (SDMT) may be a better cognitive measure for the Multiple Sclerosis Functional Composite (MSFC) than the Paced Auditory Serial Addition Test (PASAT). SDMT-based MSFC shows similar reliability but improved prediction of MS disease outcomes.
Area of Science:
- Neurology
- Neuroscience
- Clinical Assessment
Background:
- The Multiple Sclerosis Functional Composite (MSFC) is a key measure of neurological disability in multiple sclerosis (MS).
- Cognitive assessment within the MSFC traditionally uses the Paced Auditory Serial Addition Test (PASAT), with the Symbol Digit Modalities Test (SDMT) emerging as a potential alternative.
Purpose of the Study:
- To compare the validity and reliability of MSFC scores derived from PASAT versus SDMT.
- To evaluate the predictive power of both MSFC versions for MS diagnosis, disease course, and work disability.
Main Methods:
- Calculated MSFC scores using both PASAT and SDMT with reference populations (NMSS Task Force, MS patients, controls).
- Assessed test-retest reliability and correlations with other clinical measures (disability, depression, fatigue) in a longitudinal cohort.
- Employed logistic regression to determine predictive validity for diagnosis, course, and work disability.
Main Results:
- Both PASAT- and SDMT-based MSFC demonstrated similar test-retest reliability and correlations with other clinical indicators.
- The SDMT-based MSFC exhibited slightly superior predictive validity for MS diagnosis, disease course, and work disability.
- Variance accounted for by both MSFC versions was comparable, suggesting similar overall performance measurement.
Conclusions:
- Both PASAT and SDMT versions of the MSFC are valid measures for assessing neurological disability in MS.
- The SDMT offers a potentially advantageous alternative to PASAT due to its slightly better predictive validity and simpler administration.
- Clinicians and researchers may consider adopting the SDMT for future MSFC calculations to enhance predictive power and ease of use.

